“The Indian pharmaceutical industry is at the center stage in the global pharmaceutical arena and Ranbaxy is at the forefront in delivering the India centric advantages to the advanced and developing countries of the world.

From a small domestic company at inception in late 60’s, Ranbaxy has grown formidably to be an integrated, research based, international pharmaceutical company with global sales in excess of one billion dollar , as envisioned by the Chief architect and visionary of today's Ranbaxy, Late Dr Parvinder Singh, Chairman and Managing Director, in the early 90's.

It is with the unwavering ' dedication ' and the ' will to win ' of Team Ranbaxy across the globe that we have traversed this journey so far.

We are committed to provide quality generics at affordable prices to the patients worldwide with a view to help bring down the healthcare costs. We are confident that our efforts would see the Company grow from strength to strength in the global generic space in the years to come. Whilst we continue to enhance the momentum of our generics business in over 125 markets, we are also accelerating our drug discovery program through collaborations and alliances .

As we move ahead we are determined to capitalize on the new opportunities based on our strong fundamentals of innovation, entrepreneurship and aggressive marketing. We remain committed to enhancing shareholder value as we actively pursue our strategy of growth through organic and inorganic means.

Today, we are amongst the Top 10 global generic companies; we are well placed to realize our aspirations of being amongst the top 5 generic companies and attain a size of US$ 5 Bn by 2012. As we step into the next phase, we are driven by our ambition, willing to invest in the growth of our people and business, marching towards the new horizon of global leadership."

Mr. Malvinder Mohan Singh
CEO & Managing Director